Trial intelligence / Profile preview

Tigecycline vs Levofloxacin in Hospitalized CAP

NCT00081575Phase 3Completed

Sponsor
Pfizer
Start
Jan 2004
Primary completion
Mar 2005
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of tigecycline in community acquired pneumonia (CAP), sponsored by Pfizer. Started Jan 2004; status: completed.

02

Drugs

tigecycline
03

Conditions

community acquired pneumonia (CAP)

Beyond the preview

Go deeper on NCT00081575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00081575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call